1 Valdespino VM, Valdespino VE. Cervical cancer screening: state of the art[J]. Curr Opin Obstet Gynecol, 2006, 18(1): 35-40.
[2]
2 Kim SE, Huang H, Zhao M, et al. Wnt stabilization of β-catenin reveals principles for morphogen receptor-scaffold assemblies[J]. Science, 2013, 340(6134): 867-870.
[3]
3 Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis[J]. Lancet, 2011, 378(9801): 1461-1484.
[4]
4 Chandrashekar C, Angadi PV, Krishnapillai R. β-Catenin expression in benign and malignant salivary gland tumors[J]. Int J Surg Pathol, 2011, 19(4): 433-440.
[5]
5 Ferrazzo KL, Neto MM, Dos Santos E, et al. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands[J]. J Oral Pathol Med, 2009, 38(9): 701-707.
[6]
6 Guha P, Kaptan E, Bandyopadhyaya G, et al. Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis[J]. Proc Natl Acad Sci USA, 2013, 110(13): 5052-5057.
[7]
7 De Oliveira JT, De Matos AJ, Gomes J, et al. Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis[J]. Glycobiology, 2010, 20(11): 1341-1352.
[8]
8 Dakeng S, Duangmano S, Jiratchariyakul W, et al. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus[J]. J Cell Biochem, 2012, 113(1): 49-60.
[9]
9 Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population[J]. Int J Cancer, 2002, 97(1): 72-81.
[10]
10 Sant’ana JM, Chammas R, Liu FT, et al. Activation of the Wnt/Beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice[J]. Anticancer Res, 2011, 31(9): 2805-2811.
[11]
11 Jawhari AU, Farthing MJ, Pignatelli M. The E-cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation[J]. J Pathol, 1999, 187(2): 155-157.
[12]
12 Lee SB, Gong YD, Park YI, et al. 2,3,6-Trisubstituted quinoxaline derivative, a small molecule inhibitor of the Wnt/beta-catenin signaling pathway, suppresses cell proliferation and enhances radiosensitivity in A549/Wnt2 cells[J]. Biochem Biophys Res Commun, 2013, 431(4): 746-752.
[13]
13 Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation[J]. Nat Rev Cancer, 2010, 10(8): 550-560.
[14]
14 George S, Barysauskas C, Serrano C, et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma[J]. Cancer, 2014, 120(20): 3154-3158.
[15]
15 Chen J, Yao D, Li Y, et al. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma[J]. Int J Mol Med, 2013, 32(3): 557-567.
[16]
16 Shu XS, Geng H, Li L, et al. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors[J]. PLos One, 2011, 6(11): e27346.
[17]
17 Samarzija I, Beard P. Hedgehog pathway regulators influence cervical cancer cell proliferation, survival and migration[J]. Biochem Biophys Res Commun, 2012, 425(1): 64-69.
